Posted By Graphene Council,
Wednesday, May 27, 2020
First Graphene Ltd, the leading global producer of advanced graphene products, has signed an exclusive supply agreement with planarTECH (Holdings) Ltd, a global leader in graphene process equipment and graphene-enabled products. First Graphene will supply high-quality PureGRAPH® nanoplatelets in large-scale volumes for use in planarTECH’s coating formulation for face masks and PPE.
Under the supply contract, planarTECH will exclusively source graphene additives from First Graphene over a 2-year term with the agreed initial minimum quantity to be 1000kg in the first year. A further 2 terms to follow the initial term included in the contract.
First Graphene recently partnered with planarTECH to develop a robust supply chain for the manufacture of innovative graphene-enhanced personal protective equipment. Initial testing of PureGRAPH® has been completed and planarTECH will use this product in their proprietary coating to provide anti-static and bacteria-resistant properties to their range of face masks.
planarTECH has been experiencing increased demand for these products as world populations seek protection from airborne infection.
First Graphene has a well-established and robust supply chain for the manufacture of their high performing PureGRAPH® graphene products and have an already proven successful formulation that disperses uniformly into polymer coatings.
Craig McGuckin, Managing Director for First Graphene Ltd., said, “planarTECH have moved very quickly to test and commercialise their new range of graphene face masks and we are delighted to enter this contract to support the growth of their business. Clearly, further opportunities exist in the development of planarTECH’s other PPE equipment.”
Ray Gibbs, Chairman for planarTECH (Holdings) Ltd., said, “We have experienced substantial, rapid and qualified enquiries for the graphene mask. The 35 or so we are pursuing all require a fast turnaround of 2-3 weeks where potential orders could be very significant. This increasing demand has meant we needed to secure a robust graphene supply to ensure we met the known market demand. We have been impressed with the speed of response and high quality, consistent product from First Graphene which is crucial in urgently supplying this much needed product across the world.”
First Graphene Ltd, (“FGR” or “First Graphene “) the leading global producer of advanced graphene products and planarTECH (Holdings ) Ltd, (“ planarTECH”), a global leader in graphene process equipment and graphene-enabled products agree to collaborate on graphene enhanced personal protective equipment (PPE) products.
First Graphene and planarTECH have signed a memorandum of understanding towards developing a robust supply chain for the manufacture of innovative graphene-enhanced personal protective equipment.
planarTECH have developed an innovative face mask which utilises a graphene coating to provide anti-static and bacteria-resistant properties to the mask. Current demand for these products is high as world populations seek protection from airborne infection and planarTECH need to increase their manufacturing supply chain capability to meet growing market demand accordingly. PureGRAPH® additives are already being used in the mask application and First Graphene have the capability to supply the volumes required for this rapidly growing business.
The face mask will be manufactured by planarTECH under their 2AM brand. Washable and reusable, the mask is also resistant to bacteria and repels airborne particles. The new 2AM face mask has the potential to become an essential, everyday accessory during these uncertain times.
The two companies have agreed to collaborate to rapidly test and implement the use of PureGRAPH® materials into existing and new anti-static coatings for PPE. Materials development activities are already underway, and the companies anticipate quick progress to full-scale manufacturing of the face mask. With the anti-static coating capable of repelling airborne particles and offering bacteria-resistant properties further graphene enabled products in the PPE sector are expected to emerge.
Craig McGuckin, Managing Director for First Graphene Ltd., said, “We have been very impressed by the speed to commercialisation that planarTECH have achieved with the graphene face masks and we are pleased to support the growth of this opportunity”.
Ray Gibbs, Chairman for planarTECH (Holdings) Ltd., said, “For successful growth of our business, planarTECH is seeking a graphene supply partner that can reliably deliver high quality consistent products. We are very aware of First Graphene’s robust supply capability delivered globally from its Australian facility. Following on from significant trials utilising PureGRAPH® materials and we are excited about this collaboration to meet the rapid growth in demand for face masks and other PPE products.”
Posted By Graphene Council,
Thursday, April 2, 2020
UK-based planarTECH Ltd is pleased to announce an agreement with Thailand-based IDEATI Co Ltd. to market and distribute its 2AMTM line of graphene-enhanced bullet-proof vest and ballistic plate products for body armour.
According to a recent report from market research firm Grand View Research, Inc., “The global body armor market size is expected to reach USD 3.0 billion by 2025, expanding at a CAGR of 5.5% over the forecast period. The evolution of warfare has largely become asymmetric in nature and includes counter-terrorism and counter-insurgency. Similar scenarios exist in the law enforcement sectors, wherein felons, criminals, and law offenders are capable of fatally injuring responding officers, thus necessitating the demand for body armor equipment.”
IDEATI’s 2AMTM products are now in mass production for delivery to the Royal Thai Army, which has certified the products per National Institute of Justice (NIJ) standards. International testing is now underway. Minimum order quantity is 1,000 units with a lead time of 90 to 120 days.
We recognize planarTECH as a leader in the graphene industry and looking forward to using its international network to enhance our own sales efforts starting with a revolutionary bullet-proof vest.”— Ted P. Thirapatana, Director of IDEATI states
2AM™ material is a patent-pending Graphene+UHMWPE (Ultra-High-Molecular-Weight PolyEthylene) composite that leverages the strength enhancing characteristics of graphene to create ultra-lightweight body armour. 2AMTM product A-10418, for example, is currently the thinnest (20mm) and lightest (1.8kg) NIJ Level IV standalone plate available on the market. Moreover, the addition graphene to the composite can reduce backface deformation to just 11.3 mm.
Patrick Frantz, Founder & CEO of planarTECH commented,
“planarTECH has been involved in the development of 2AMTM technology from its inception and we’re very pleased to see that it has finally achieved commercial viability and become a commercial product for sale in the market. We want to support the sales of this technology through our own networks and are already actively engaging potential customers in the USA, UK, Israel, Turkey, Saudi Arabia, India and China. We also believe that this technology has other applications beyond personal body armour, which we are currently exploring.”
Ted P. Thirapatana, Director of IDEATI states,
“We are very proud to have co-developed this cutting-edge graphene technology in Thailand and that our 2AMTMlight-weight bullet-proof material for ballistics and high-impact applications is now ready for sale in the global market. We recognize planarTECH as a leader in the graphene industry and we’re looking forward to using its international network to enhance our own sales efforts starting with a revolutionary bullet-proof vest.”
Posted By Graphene Council,
Friday, March 20, 2020
These are scary times, aren't they? First and foremost, my thoughts and prayers go out to anyone who is directly affected by the current global crisis caused by the SARS-CoV-2 coronavirus. It's an extremely serious issue that will require worldwide cooperation to overcome.
I have very clear and distinct memories of the previous SARS epidemic. In March 2003, while working at Rice University, I was helping to lead a group of ~50 science and engineering students on an overseas study trip to Hong Kong and Singapore with my former Rice colleague, Dr. Cheryl Matherly (who is now at Lehigh University). We were caught in the middle of the rapidly developing crisis and our travel itinerary had us departing Singapore for Hong Kong on the day the Singapore government warned its own citizens not to travel to Hong Kong!
Fortunately, everyone in our student group made it through that experience safely, and as unsettling as it was, the current situation is much much worse, with as yet unknown - but sure to be significant - social, economic and political ramifications that will most definitely impact future generations around the world.
I am currently based in Bangkok, Thailand, which is a global tourist destination. While we were fortunately to escape the first wave of of the SARS-CoV-2 virus that emanated from China, we're now faced with a second wave imported from Europe. We're not quite under total lockdown here, but things appear to be headed in that direction. It is clear to me form observation that the several governments in the region (Singapore, Hong Kong, and Taiwan, to be specific) are applying the lessons they learned from the previous SARS epidemic to help control the current pandemic. This give me hope, and the circumstances in general have given me plenty of time to think and reflect about what - if anything - I and my company, planarTECH, can do to improve this situation.
Graphene: The "Wonder Material"
I was lucky to fall into the world of graphene and 2D materials by accident through acquaintance with another former Rice University colleague, Dr. James Tour, and conversations I had with him 8 years ago. I will not spend a lot of time here talking about the specific properties of graphene as such information is widely available. The European Union's Graphene Flagship project, for example, has an excellent overview. The University of Manchester - where graphene was first isolated and where planarTECH's Chairman, Ray Gibbs, currently serves as the Director of Commercialization for the Graphene Engineering and Innovation Centre - also has a fantastic YouTube channel with many instructive videos about graphene and its properties.
With all of the amazing properties of graphene, the question is, can it offer any kind of solution to the current pandemic and global crisis?
Academic Work: Graphene's Antiviral Properties
The short answer to the question above is "possibly," but with some caveats. In particular, it would appear that graphene oxide (GO) may play a role in providing a solution.
I should say that I am not a doctor, an epidemiologist or someone with formal training in the biological sciences. I am an engineer by trade, and for the last 8 years, an entrepreneur in the field of graphene. However, since entering the graphene industry, I have grown accustomed to reading academic papers in order to understand the potential applications for graphene.
A paper published in 2015 by researchers at the Huazhong Agricultural University (ironically located in Wuhan, China, where the current pandemic originated) explored the antiviral properties of graphene oxide, and the authors of the paper concluded "that GO and rGO exhibit broad-spectrum antiviral activity toward both DNA virus (PRV) and RNA virus (PEDV) at a noncytotoxic concentration," and that "the broad-spectrum antiviral activity of GO and rGO may shed some light on novel virucide development." While encouraging, it should be noted that the researchers looked specifically at pseudorabies virus (PRV) and porcine epidemic diarrhea virus (PEDV), not the SARS-CoV-2 virus responsible for the current global pandemic.
Another paper published in 2017 by researchers at Southwest University in China looked at cyclodextrin functionalized graphene oxide and it's possible role in combatting respiratory syncytial virus (RSV), concluding that "the curcumin loaded functional GO was confirmed with highly efficient inhibition for RSV infection and great biocompatibility to the host cells." Likewise, a third paper published in 2019 by researchers at Sichuan Agricultural University in China demonstrated that "GO/HY [graphene oxide/hypericin] has antiviral activity against NDRV [novel duck reovirus] both in vitro and in vivo."
The conclusion we can draw from these works is that graphene oxide may offer a platform to fight a variety of viral infections (such as the SARS-CoV-2 coronavirus), possibly as some form of coating, though certainly more work needs to be done.
(Note that my good friends over at The Graphene Council had a recent and excellent blog post covering the same 3 articles in a little more detail. And kudos to them for shining light on the topic before me!)
Productization: From Lab to Market
If there's one thing I've learned from the past 8 years being involved with graphene commercialization (and the past 14 years working directly in the Asian supply chain) is that it is one matter to write an excellent academic paper as a proof-of-concept, but it is an entirely different matter to take work from an academic lab and turn it into a real product.
With respect to graphene in general, what we are seeing today is definite movement on the Gartner hype cycle from the Trough of Disillusionment to the Slope of Enlightenment. Real products using graphene are now on the market. One such example is the recent announcement of of a collaboration between UK-based Haydale Graphene Industries plc and Korea-based ICRAFT Co., Ltd. that results in the release of a graphene cosmetic face mask. And I am pleased to be able to say that - in connection with my previous responsibilities for Haydale's Asia-Pacific operations - I had some role (together with my colleague Yong-jae "James" Ji) in getting this product off the ground and into the marketplace.
While this may seem like a trivial accomplishment given the context and seriousness of the current global pandemic, I offer this example as proof that graphene can be utilized in an everyday, cost-sensitive product, and it is not such a great conceptual leap to go from a cosmetic face mask to a protective face mask, which as we all know are in great demand these days (especially here in Asia). I would invite iCRAFT (or anyone else) to consider collaboration with planarTECH to develop such a product. (Above photo courtesy of Macau Photo Agency on Unsplash.)
Productization: Existing Products?
Very much related to this topic and very curious is a recent public announcement by LIGC Applications of its Guardian G-Volt face mask with a graphene-based filtration system. However, my understanding is that LIGC is not employing graphene specifically for it's potential antiviral properties but rather for its potential to enhance a filtration system, including (due to graphene's electrical conductivity) the ability to pass an electrical charge through the mask that "would repel any particles trapped in the graphene mask."
What I find very curious about this case is that subsequent to this announcement, LIGC's Indiegogo crowdfunding campaign, which was live, has now been placed under review, and the company's pitch video on YouTube has likewise been made private. I do not know what has happened here - perhaps is was perceived as poor timing? - but as a fellow entrepreneur who is conducting my own crowdfunding campaign, I wish LIGC the best of luck with its product development and ultimate launch. I definitely want to see more viable graphene products in the marketplace.
The Graphene Supply Chain: planarTECH's Role
One of the challenges the graphene industry faces overall is scalability. Very few graphene companies today (if any at all) can produce graphene at the scale, at the right cost, and with the consistent quality such that it can be used for truly high-volume applications. Over the past 8 years, I have met numerous customers, mostly in Asia, who want to use graphene in their products but cannot find a secure and stable supply that meets their expectations on specification, volume, and price.
At planarTECH we're interested in not only the end applications, but also in solving this problem of production scalability. While we have in the past mainly been focused on production systems for graphene and other 2D materials by Chemical Vapor Deposition (CVD), we also recently started offering continuous flow production systems for graphene oxide, which we believe can take graphene oxide production from lab-scale, high-cost (grams per week) to production-scale, low-cost (kilograms per hour). We're actively seeking partners to work with us on setting up production and exploration of the application space for graphene oxide, and we're currently conducting a crowdfunding campaign on Seedrs to help us expand our business and make graphene a commercial reality. As seen above, we think graphene oxide's antiviral properties can be exploited to make new and useful products.
I should clarify and caution that planarTECH is not in the position today to offer a graphene-based product that can immediately help alleviate current crisis and prevent widespread infection. Unfortunately, such a product is realistically 1-2 years away. But what we can offer is market expertise specific to graphene, production technologies, and experience in taking products from the idea phase to a reality in the marketplace.
Conclusion: Graphene is a Possible Solution
To conclude, I would like to reiterate a few broad points.
• Graphene (graphene oxide in particular) and coatings made from graphene would appear to have antiviral properties as reported in several published academic papers.
• Real commercial products exist that use graphene, but the industry as a whole still faces challenges around scalability, cost and quality.
• An immediate graphene-based solution to alleviate the effects of the global SARS-CoV-2 coronavirus pandemic is likely unrealistic, but could be possible in the future.
• planarTECH has a role in the supply chain and is seeking partners, as well as investors via its crowdfunding campaign, to expand its business and help end customers develop useful products.